PARTNERSHIPS FOR NOVEL THERAPEUTIC, DIAGNOSTIC AND VECTOR CONTROL STRATEGIES
IN INFECTIOUS DISEASES ADDENDUM TO PAR-02-026
Release Date: April 10, 2002
NOTICE: NOT-AI-02-013 (also see PAR-02-026, NOT-AI-02-22, NOT-AI-02-007)
National Institute of Allergy and Infectious Diseases (NIAID)
(http://www.niaid.nih.gov/default.htm)
Letter of Intent Receipt Date: May 20, 2002
Application Receipt Date: June 20, 2002
The National Institute of Allergy and Infectious Diseases is removing
language as well as stating the letter of intent receipt date previously
omitted. The NIAID would also like to announce that additional initiatives
relating to the areas of Bio-Defense and Influenza will soon be published in
the "NIH Guide".
The Letter of Intent receipt date for the second receipt date is May 20,
2002. The Application receipt date had been changed to June 20, 2002, as
announced in NOT-AI-02-007 at http://grants.nih.gov/grants/guide/notice-
files/NOT-AI-02-007.html
Under Research Objectives and Scope, area #4 will be removed and addressed in
upcoming initiatives:
#4. Development of Vaccines for Selected Agents of Bioterrorism:
Responsive applications to scientific area "4." include those that propose to
develop vaccines to prevent infection and/or disease from CDC Category A
agents of bioterrorism (B. anthracis, Clostridium botulinum. Yersinia pestis,
Variola major, Francisella tularensis and causative pathogens of viral
hemorrhagic fevers). Proposed research may fall anywhere along a broad
spectrum of activities from candidate identification and validation through
preclinical development and early human testing (Phase I and II trials).
Also note that applications relating to Influenza will also not be accepted
under this PAR. An announcement coming out in the next few months will apply
to both the above areas.
Complete information about the grant program, PAR-02-026, may be obtained at
http://www.niaid.nih.gov/ncn/pa/PAR-02-026.html.
INQUIRIES
Written and telephone inquiries are encouraged. The opportunity to clarify
any issues or questions from potential applicants is welcome.
Direct inquiries regarding programmatic, research scope, and eligibility
issues to:
Ann M. Ginsberg, M.D., Ph.D.
Division of Microbiology and Infectious Diseases
National Institute of Allergy and Infectious Diseases
Room 3133, MSC-7630
6700-B Rockledge Drive
Bethesda, MD 20892-7630
Telephone: (301) 496-5305
FAX: (301) 496-8030
E-Mail: ag73i@nih.gov
Direct inquiries regarding fiscal matters to:
Ms. Jeanette Gordon
Division of Extramural Activities
National Institute of Allergy and Infectious Diseases
Room 3222, MSC-7614
6700-B Rockledge Drive
Bethesda, MD 20892-7614
Telephone: (301) 402-5065
Fax: (301) 480-3780
E-mail: jgordon@niaid.nih.gov
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
|
|
|
Department of Health and Human Services (HHS)
|
|
|
|
NIH... Turning Discovery Into Health®
|